Menu
Enrolling by invitation NCT06917794

Development of Polygenic Risk Scores in Colon Cancer Patients Through the Study of Ancestry and Diversity in Genetic Maps of the Brazilian Population - ORIGEM Project

Observational Colo-rectal Cancer Polygenic Risk Score Somatic Mutation Hereditary Cancer

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Colo-rectal Cancer, Polygenic Risk Score, Somatic Mutation, Hereditary Cancer. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Brazil
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Development of a polygenic risk score based on somatic and germline genetic information from patients with colorectal cancer

Detailed description

Colorectal cancer (CRC) is the third most common cancer diagnosed in both men and women. Approximately 70% of CRC cases originate from spontaneous point mutations in oncogenes, tumor suppressor genes, and genes related to DNA repair mechanisms (Nigin et al., 2023). The remaining 30% result from hereditary mutations, of which 5-6% involve high-penetrance genes. Genetic predisposition due to pathogenic germline variants in high-risk cancer-associated genes has been implicated in 2-8% of all CRC cases, increasing to 6-10% when considering pathogenic mutations in both high- and moderate-penetrance genes.

For individuals with certain hereditary cancer syndromes, the risk of developing colorectal cancer can reach 50-80% in the absence of endoscopic and/or surgical intervention. Therefore, characterizing high-, moderate-, and low-penetrance genes within a population is crucial for understanding hereditary tumorigenesis and guiding more cost-effective screening strategies.

Genetic studies comparing genomes from populations of different ethnic backgrounds have demonstrated that ancestry plays a significant role in genetic predisposition to CRC. Given the high level of genetic admixture in the Brazilian population, studies focused solely on populations of European ancestry fail to provide a representative model for application in highly admixed populations like Brazil.

In this context, the present study aims to utilize next-generation sequencing (NGS) in a cohort representative of the Brazilian population with CRC and controls to develop a Polygenic Risk Score (PRS). This score could impact cancer screening and prevention strategies, as well as genetic counseling for patients and their families. The hypothesis is that genetic mapping-including ancestry, germline, and tumor genetic variability-in Brazilian colorectal cancer patients will provide valuable data for developing a PRS that may eventually guide more targeted and cost-effective screening strategies for our population.

Primary outcome measures

  • Elaboration of Poligenic Risk [Time frame: 36mo]

Eligibility criteria

Inclusion criteria

  • > 18 years;
  • Histologically confirmed diagnosis of colorectal cancer;
  • Have available tumor material for somatic sequencing, obtained from biopsy or routine surgery;
  • Sign the informed consent form (ICF) for the study.

Exclusion criteria

  • Pregnants

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Brazil · 9 centers
  • Instituto D'Or de Pesquisa e Ensino — Fortaleza
  • CPOC - Centro de Pesquisa Oncológica e Clínica, faz parte do Complexo Associação Obras Soc — Salvador
  • Instituto D'Or de Pesquisa e Ensino — Salvador
  • Instituto D'Or de Pesquisa e Ensino — Brasília
  • Instituto D'Or de Pesquisa e Ensino — Curitiba
  • Instituto D'Or de Pesquisa e Ensino — Recife
  • Instituto D'Or de Pesquisa e Ensino — Rio de Janeiro
  • Instituto D'Or de Pesquisa e Ensino — São Paulo
  • … and 1 more center

Identifiers

NCT: NCT06917794 · 25000.130491/2023-48 - ORIGEM

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗